Nikitina V, Santi Laurini G, Montanaro N, Motola D, et al. Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab. Headache 2025 May 29. doi: 10.1111/head.14962.
PMID: 40439253